[Treatment with antiplatelet drugs. Current status of knowledge].
D001241:Aspirin / Q000627:therapeutic use; D001791:Blood Platelet Disorders / Q000188:drug therapy*; D002561:Cerebrovascular Disorders / Q000188:drug therapy / Q000517:prevention & control; D002994:Clofibrate / Q000627:therapeutic use; D003327:Coronary Disease / Q000188:drug therapy / Q000517:prevention & control; D003911:Dextrans / Q000627:therapeutic use; D004176:Dipyridamole / Q000627:therapeutic use; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006350:Heart Valve Prosthesis / Q000009:adverse effects; D006801:Humans; D006886:Hydroxychloroquine / Q000627:therapeutic use; D010974:Platelet Aggregation / Q000187:drug effects; D011183:Postoperative Complications / Q000188:drug therapy / Q000517:prevention & control; D013442:Sulfinpyrazone / Q000627:therapeutic use; D013923:Thromboembolism / Q000188:drug therapy / Q000517:prevention & control
D003911:Dextrans; D005343:Fibrinolytic Agents; D006886:Hydroxychloroquine; D004176:Dipyridamole; D002994:Clofibrate; D001241:Aspirin; D013442:Sulfinpyrazone
La terapia con farmaci antipiastrinici. Stato attuale delle conoscenze.